F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fluidigm Corp
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluidigm Corp
F:FLB
Accounts Receivables
$35.3m
CAGR 3-Years
37%
CAGR 5-Years
20%
CAGR 10-Years
8%
Thermo Fisher Scientific Inc
NYSE:TMO
Accounts Receivables
$9.8B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Accounts Receivables
$3.5B
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Accounts Receivables
$637.2m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accounts Receivables
$1.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Accounts Receivables
$3.2B
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
12%
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
703.6m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.67 EUR
Overvaluation 64%
Intrinsic Value
Price
F

See Also

What is Fluidigm Corp's Accounts Receivables?
Accounts Receivables
35.3m USD

Based on the financial report for Sep 30, 2024, Fluidigm Corp's Accounts Receivables amounts to 35.3m USD.

What is Fluidigm Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
8%

Over the last year, the Accounts Receivables growth was 113%. The average annual Accounts Receivables growth rates for Fluidigm Corp have been 37% over the past three years , 20% over the past five years , and 8% over the past ten years .

Back to Top